Med Lasers.  2023 Jun;12(2):96-101. 10.25289/ML.23.014.

Therapeutic effect of the R0 method on tattoo removal in Republic of Korea: retrospective clinical study

Affiliations
  • 1Department of Dermatology, Myongji Hospital, Goyang, Republic of Korea
  • 2Yonsei Star Skin and Laser Clinic, Seoul, Republic of Korea
  • 3Department of Dermatology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea

Abstract

Background
Compared with a single pass, improvements in tattoo fading have been seen when multiple passes per session are used. Multiple-pass tattoo removal using perfluorodecalin to deliver rapid sequential passes (R0 method) requires a short total treatment time of 5 minutes and is more effective than the singlepass treatment. However, very few studies have been conducted on the R0 method for removing tattoos in Republic of Korea. We, therefore, studied the efficacy and safety of this method for the removal of tattoos.
Methods
A total of 20 Korean patients with tattoos were treated with a Nd:YAG picosecond laser in our clinic, with a fluence of 1.0-3.4 J/cm2 , a spot size of 3.0-5.0 mm, and wavelengths of 532, 730, 785, and 1,064 nm. The patients received four treatments at 4-week intervals. On completion of the treatment, two dermatologists, who were not associated with the study, evaluated the photographs taken before and after treatment to assess tattoo lightening.
Results
Of the 20 patients, 6 showed excellent (more than 90% clearance) and 14 showed good (70%-90% clearing) results. After the procedure, while there was some temporary blistering or pigmentation, there were no long-term side effects, such as scarring.
Conclusion
The R0 method using a picosecond laser is an effective and safe treatment for removing tattoos in Korean patients.

Keyword

Laser therapy; Nd-YAG lasers; Tattoo removal; Perfluorodecalin
Full Text Links
  • ML
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr